NCT03892811

Brief Summary

The purpose of this study is to evaluate the effect of nipple flow rate on swallowing function in infants less than 3 months corrected age (up to 11 weeks and 6 days) who have been referred for videofluoroscopic swallow study.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2018

Shorter than P25 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2018

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2019

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

February 6, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 27, 2019

Completed
Last Updated

June 11, 2021

Status Verified

June 1, 2021

Enrollment Period

12 months

First QC Date

February 6, 2019

Last Update Submit

June 9, 2021

Conditions

Outcome Measures

Primary Outcomes (7)

  • VFSS - number of sucks per swallow

    Number of sucks per swallow for each of 10 swallows under each of the three study conditions.

    Through completion of 10 swallows under each study condition, maximum of 1 minute per study condition.

  • VFSS - oral bolus control

    Oral bolus control for each of 10 swallows under each of the three study conditions.

    Through completion of 10 swallows under each study condition, maximum of 1 minute per study condition.

  • VFSS - location of swallow onset

    Location of swallow onset for each of 10 swallows under each of the three study conditions.

    Through completion of 10 swallows under each study condition, maximum of 1 minute per study condition.

  • VFSS - presence of pharyngonasal regurgitation

    Presence of pharyngonasal regurgitation for each of 10 swallows under each of the three study conditions.

    Through completion of 10 swallows under each study condition, maximum of 1 minute per study condition.

  • VFSS - presence of laryngeal penetration

    Presence of laryngeal penetration for each of 10 swallows under each of the three study conditions.

    Through completion of 10 swallows under each study condition, maximum of 1 minute per study condition.

  • VFSS - presence of aspiration (silent or non-silent)

    Presence of aspiration (silent or non-silent) for each of 10 swallows under each of the three study conditions.

    Through completion of 10 swallows under each study condition, maximum of 1 minute per study condition.

  • VFSS - presence of post-swallow residue

    Presence of post-swallow residue for each of 10 swallows under each of the three study conditions.

    Through completion of 10 swallows under each study condition, maximum of 1 minute per study condition.

Study Arms (1)

Infants referred for swallow study

This is a within-subjects intervention study where each infant in the study will receive all three conditions. The three study conditions are bottle-feeding with 1) Dr. Brown's Ultra-Preemie bottle nipple, 2) Dr. Brown's Preemie bottle nipple, and 3) Dr. Brown's Level 1 bottle nipple.

Other: Three study conditions

Interventions

Continuous fluoroscopy (at 30 frames/second) will be used for intermittent periods to capture 10 swallows in the initial sucking sequence of each of three study conditions: 1) Dr. Brown's Ultra-Preemie bottle nipple, 2) Dr. Brown's Preemie bottle nipple, and 3) Dr. Brown's Level 1 bottle nipple.

Infants referred for swallow study

Eligibility Criteria

Age12 Hours - 3 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Infants less than 3 months corrected age (up to 11 weeks and 6 days) who have been referred for video fluoroscopic swallow study.

You may qualify if:

  • Infant less than 3 months corrected age
  • Must be referred for video fluoroscopic swallow study (VFSS) at Boston Children's Hospital

You may not qualify if:

  • \- Infant unsafe to trial all study conditions as determined by clinician(s) conducting the VFSS.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Pados BF, Park J, Dodrill P. Know the Flow: Milk Flow Rates From Bottle Nipples Used in the Hospital and After Discharge. Adv Neonatal Care. 2019 Feb;19(1):32-41. doi: 10.1097/ANC.0000000000000538.

    PMID: 30028734BACKGROUND
  • Pados BF, Thoyre SM, Estrem HH, Park J, Knafl GJ, Nix B. Effects of milk flow on the physiological and behavioural responses to feeding in an infant with hypoplastic left heart syndrome. Cardiol Young. 2017 Jan;27(1):139-153. doi: 10.1017/S1047951116000251. Epub 2016 Mar 16.

    PMID: 26982280BACKGROUND

MeSH Terms

Conditions

Bottle Feeding

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Study Officials

  • Stephanie A DiPerna, MD

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
AP - Medical Staff, Radiology - Diagnostic

Study Record Dates

First Submitted

February 6, 2019

First Posted

March 27, 2019

Study Start

February 1, 2018

Primary Completion

January 30, 2019

Study Completion

January 30, 2019

Last Updated

June 11, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will share

De-identified individual participant data will be made available in a secure Database.

Time Frame
Data will be made available 2 years after study completion.
Access Criteria
Data access requests will be reviewed by the research team.